Evidence map›Paper›PMID 19502387›Full record

ArticleAmerican journal of respiratory cell and molecular biology2010

TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.

Gerrit John, Ali O Yildirim, Bruce K Rubin, Dieter C Gruenert, Markus O Henke

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Journal of fungi (Basel, Switzerland) · 2025
    Review
  6. Review
  7. American journal of respiratory cell and molecular biology · 2024
    Article
  8. Review
  9. Frontiers in immunology · 2024
    Review
  10. On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI).European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2023
    Review
  11. Review
  12. Article
  13. Airway Epithelial Cells Differentially Adapt Their Iron Metabolism to Infection WithFrontiers in cellular and infection microbiology · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Gerrit JohnPhilipps-University Marburg, Department of Pulmonary Medicine, Baldingerstrasse 1, 35043 Marburg, Germany.
Ali O Yildirim
Bruce K Rubin
Dieter C Gruenert
Markus O Henke
Philipps University of Marburg · DEPulmonary Associates · USUniversity of California, San Francisco · USWake Forest University · US

Funding

Generation of a CF Pig by SFHR and Nuclear TransferR21DK066403 · NIDDK · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI GRUENERT, DIETER C · 2004 to 2005
$320k
Development of a Genetic Therapy for CF in a CF RabbitR41HL080814 · NHLBI · EVERGEN BIOTECHNOLOGIES, INC. · PI GRUENERT, DIETER C · 2005 to 2005
$140k
NHLBI NIH HHS R41 HL080814NIDDK NIH HHS R21 DK066403
6 · The paper itself

Abstract

Airway epithelial cells contribute to the inflammatory response of the lung, and their innate immune response is primarily mediated via Toll-like receptor (TLR) signaling. Cystic fibrosis (CF) airways are chronically infected with Pseudomonas aeruginosa, suggesting a modified immune response in CF. We investigated the TLR-4 expression and the inflammatory profile (IL-8 and IL-6 secretion) in CF bronchial epithelial cell line CFBE41o- and its CF transmembrane ion condcutance regulator (CFTR)-corrected counterpart grown under air-liquid interface conditions after stimulation with lipopolysaccharide (LPS) from gram-negative bacteria. In CFTR-corrected cells, IL-8 and IL-6 secretions were constitutively activated but significantly increased after LPS stimulation compared with CFBE41o-. Blocking TLR-4 by a specific antibody significantly inhibited IL-8 secretion only in CFTR-corrected cells. Transfection with specific siRNA directed against TLR-4 mRNA significantly reduced the response to LPS in both cell lines. Fluorescence-activated cell sorter analysis revealed significantly higher levels of TLR-4 surface expression in CFTR-corrected cells. In histologic lung sections of patients with CF, the TLR-4 expression in the bronchial epithelium was significantly reduced compared with healthy control subjects. In CF the loss of CFTR function appears to decrease innate immune responses, possibly by altering the expression of TLR-4 on airway epithelial cells. This may contribute to chronic bacterial infection of CF airways.

Indexed as

Immunity, InnateAdolescentAdultAntibodiesBronchiCell LineChildCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsFemaleGene Expression RegulationHumansInterleukin-6Interleukin-8LipopolysaccharidesAntibodiesCFTR protein, humanCXCL8 protein, humanCystic Fibrosis Transmembrane Conductance RegulatorIL6 protein, humanInterleukin-6Interleukin-8LipopolysaccharidesRNA, MessengerTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID19502387
PMCPMC5459530
OpenAlexW2053522380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.